Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole

NCT00268554 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hyperemia
Hypoxia

Interventions

DRUG: dipyridamole
DRUG: caffeine

Sponsor

Radboud University Medical Center